13,399 Shares in Billiontoone, Inc. $BLLN Acquired by Sei Investments Co.

Sei Investments Co. acquired a new stake in shares of Billiontoone, Inc. (NASDAQ:BLLN) during the 1st quarter, HoldingsChannel.com reports. The fund acquired 13,399 shares of the company’s stock, valued at approximately $1,058,000.

Other large investors also recently added to or reduced their stakes in the company. Rossby Financial LCC acquired a new position in shares of Billiontoone during the 4th quarter worth $25,000. Wells Fargo & Company MN acquired a new position in Billiontoone during the fourth quarter worth $76,000. Smartleaf Asset Management LLC acquired a new position in Billiontoone during the fourth quarter worth $80,000. Nano Cap New Millennium Growth Fund L P bought a new position in Billiontoone during the fourth quarter valued at about $82,000. Finally, Renaissance Capital LLC bought a new position in Billiontoone during the fourth quarter valued at about $201,000.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on BLLN shares. JPMorgan Chase & Co. decreased their price target on Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a research note on Thursday, August 6th. Weiss Ratings raised Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. Wall Street Zen downgraded shares of Billiontoone from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Guggenheim began coverage on shares of Billiontoone in a research note on Monday, June 29th. They issued a “buy” rating and a $125.00 target price on the stock. Finally, BTIG Research dropped their target price on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. Six research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $126.71.

Billiontoone Trading Down 0.5%

Shares of BLLN stock opened at $97.45 on Thursday. The firm has a fifty day moving average of $116.70 and a 200-day moving average of $94.55. The stock has a market cap of $4.48 billion and a price-to-earnings ratio of 139.21. Billiontoone, Inc. has a 52-week low of $61.96 and a 52-week high of $150.44. The company has a debt-to-equity ratio of 0.17, a quick ratio of 11.31 and a current ratio of 11.69.

Billiontoone (NASDAQ:BLLN) last issued its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. The business had revenue of $109.45 million for the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. On average, equities research analysts forecast that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Insider Transactions at Billiontoone

In other Billiontoone news, CTO David Tsao sold 20,000 shares of the company’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $102.27, for a total value of $2,045,400.00. Following the sale, the chief technology officer directly owned 1,000 shares in the company, valued at $102,270. This represents a 95.24% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of the stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $136.95, for a total value of $4,450,875.00. Following the transaction, the chief executive officer owned 20,000 shares of the company’s stock, valued at $2,739,000. This represents a 61.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 213,466 shares of company stock valued at $24,557,044. Corporate insiders own 50.22% of the company’s stock.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.